Not sure where you are getting that it was only for the brain volume data?
"The change of clinical scores from baseline to Week 48 was analyzed as the dependent variable, with treatment and visit week as fixed effects, treatment-by-visit as interaction effect, and baseline score, country, baseline concomitant AD medication, natural logarithm of the baseline plasma Nf-L concentration, baseline MMSE status, and SIGMAR1 receptor gene variant genotype status (single-nucleotide polymorphism SIGMAR1 rs1800866 presence or absence) as covariates in the model."
Market Data 
Markets 
AI
